Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 23, 2016
Patent Application Number
13876465
Date Filed
September 30, 2011
Patent Citations Received
Patent Primary Examiner
Patent abstract
The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
